Vaisala CorporationPress releaseApril 8, 2026, at 8:30 a.m. (EEST) Vaisala’s Interim Report January–March 2026 to be published on April 24, 2026 Vaisala Corporation will publish its Interim Report January–March 2026 on Friday, April 24, 2026, at about 9:00 a.m. (EEST). The report will be available at vaisala.com/investors. The President and CEO’s presentation will be published by 12:30 p.m. on the same day at vaisala.com/investors. Audiocast and teleconference An audiocast and a conference call for analysts, investors, and media will be held in English on the same day, starting at 12:30 p.m. (EEST). You can participate in the live audiocast via the following link: https://vaisala.events.inderes.com/q1-2026 Questions may be presented by participating in the teleconference. You can access the teleconference by registering at...

Paris (France), April 8, 2026 Viridien upgraded to “B” by S&P, following rating confirmations by Moody’s and Fitch Viridien announces today that Standard & Poor’s (S&P) has upgraded its long-term credit rating to “B”, with a stable outlook, reflecting the Company’s solid operational execution. The previous rating was “B-” with a positive outlook. In parallel, the rating on the Company’s senior secured notes has been raised to “B+”, from “B” previously. S&P highlighted that “the company has built a positive track record of more stable performance over the past couple of years in a volatile market environment, benefiting from the end of the costly Shearwater contract in 2025, as well as a focus on cost control and higher-value projects.” This upgrade follows the recent confirmation of Viridien’s corporate rating by Moody’s...

DUBAI, United Arab Emirates, April 08, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Aurélien Vincent as a Senior Managing Director in the Strategy & Transformation practice within the firm’s Corporate Finance segment. Mr. Vincent, who is based in Dubai, will lead the firm’s financial services capabilities in the Middle East. He will support clients across the banking, capital markets, asset management and fintech sectors, as well as financial regulators and public and development finance institutions, with structural change, digitisation and transformation programmes and initiatives. “Aurélien’s appointment shows our ongoing investment to grow our Strategy & Transformation capabilities in the region,” said Antoine Nasr, Head of FTI Consulting Middle East. “His extensive experience...

Press ReleaseRegulated Information08 April 2026, 7:00 am CET, Antwerp, Belgium The shareholders of VGP NV (the “Company”) are hereby invited to attend the annual shareholders’ meeting, the special shareholders’ meeting and the extraordinary shareholders’ meeting of the Company which shall consecutively take place at The Mills, Molenstraat 54, 2018 Antwerp, Belgium, on Friday 8 May 2026 at 10:00 am. Please consult the website link: www.vgpparks.eu/en/investors/shareholder-meetings/ for further information concerning the agenda, admission conditions and voting modalities for the Meetings. The Board of Directors CONTACT DETAILS FOR INVESTORS AND MEDIA ENQUIRIESInvestor Relations Tel: +32 (0)3 289 1433investor.relations@vgpparks.euABOUT VGP VGP is a pan-European owner, manager and developer of high-quality logistics and semi-industrial...

OSLO, NORWAY (8 April 2026) – The annual general meeting of TGS ASA (“TGS” or the “Company”) will be held on 29 April 2026 as a virtual meeting through the facilities of Lumi at 17:00 hours (Oslo time). The notice for the annual general meeting is attached hereto (English and Norwegian), including relevant appendices. The notice will be sent to all registered shareholders on 8 April 2026. To register your attendance, grant proxy or cast votes electronically in advance through VPS Investor Services, please use the following link:https://investor.vps.no/gm/logOn.htm?token=7b84780e9128370866b336da8f9f4423c61f2903&validTo=1780066800000&oppdragsId=20260323VPLP01U0 The pin code and reference number, which are sent out with the notice, will be needed. Shareholders that have received the notice electronically...

Petersala visualisation 1Petersala visualisation 1Petersala visualisation 2Petersala visualisation 2SIA Merko Mājas, part of the AS Merko Ehitus group, has launched the residential development project in Riga’s prestigious and Quiet Centre at Pētersalas street 3 and 5 in Riga. The architectural ensemble of four elegant buildings will comprise a total of 105 new homes and four commercial units, scheduled for completion in the summer of 2028. Merko Mājas will reconstruct two architecturally significant heritage buildings, named Valensis and Selonija, designed by renowned Latvian architect Konstantīns Pēkšēns, who authored more than 250 notable buildings in Riga at the turn of the 20th century. The two new buildings in the quarter will be named Fera and Amia. The buildings of the Pētersala project (petersala.merkomajas.lv)...

Press Release Secure. Compliant. European. Meet Tiris: The Sovereign Messaging Platform. Copenhagen, 8 April 2026 Trifork today announces the launch of Tiris Messenger, a secure, sovereign communication platform designed for European enterprises and public sector organizations. Developed to meet the growing need for data protection, regulatory compliance, and digital sovereignty, Tiris Messenger provides a trusted, European-built foundation for modern enterprise communication. Tiris Messenger is an end-to-end encrypted messaging platform engineered for organizations operating in highly regulated environments. Developed and hosted in Denmark, the solution ensures that all data remains within Europe, offering a secure alternative to non-European communication platforms. As regulatory frameworks such as NIS2 Directive and General Data Protection...

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients ~15,000 children are living with DMD in the U.S. NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to directly proceed for a registrational clinical trial evaluating Ryoncil® (remestemcel-L-rknd) in Duchenne muscular dystrophy (DMD), which affects approximately 15,000 children in the U.S.1 Ryoncil® is the first mesenchymal stromal cell (MSC) product approved by FDA, and the only product approved for children under age 12 with steroid-refractory acute graft-versus-host disease (SR-aGvHD)2....